FDA expands COVID-19 testing options via spun synthetic swabs
The Food and Drug Administration yesterday announced that spun synthetic swabs made from materials like polyester can be used for test patients for COVID-19.
FDA based its decision on a clinical investigation that revealed that synthetic swabs can be used for front-of-the-nose testing, which is considered more comfortable for patients, allows for self-testing and limits health care providers’ exposure. To support this declaration, U.S. Cotton says it will produce these new polyester swabs in large quantities to help meet coronavirus diagnostic testing needs.
Related News Articles
Headline
Leaders of the Food and Drug Administration May 20 announced new guidelines for administering the COVID-19 vaccine in a paper published by the New England…
Headline
A study published April 8 by the Public Library of Science’s Journal of Global Public Health found that driving while infected with COVID-19 raises the risk of…
Headline
The Senate Finance Committee Feb. 4 voted 14-13 to advance Robert F. Kennedy Jr.’s nomination for secretary of the Department of Health and Human Services. A…
Headline
Respiratory illness activity remains high across the country, according to the latest data from the Centers for Disease Control and Prevention. Seasonal flu…
Headline
The Occupational Safety and Health Administration Jan. 13 announced that it terminated efforts to establish a final COVID-19 safety standard to protect workers…
Headline
The Department of Health and Human Services Dec. 10 amended the Public Readiness and Emergency Preparedness Act declaration for COVID-19, extending liability…